| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.28B | 9.87B | 10.87B | 7.99B | 8.95B | 8.08B |
| Gross Profit | 2.99B | 3.84B | 4.08B | 2.85B | 2.87B | 2.73B |
| EBITDA | 307.17M | 1.09B | 1.66B | 617.63M | 730.58M | 766.32M |
| Net Income | 224.97M | 728.30M | 2.29B | 271.19M | 414.58M | 391.74M |
Balance Sheet | ||||||
| Total Assets | 21.17B | 21.17B | 20.90B | 17.64B | 15.63B | 15.04B |
| Cash, Cash Equivalents and Short-Term Investments | 11.43B | 12.01B | 12.00B | 8.21B | 7.85B | 6.45B |
| Total Debt | 48.56M | 108.19M | 317.49M | 274.66M | 297.66M | 430.98M |
| Total Liabilities | 5.79B | 5.06B | 4.75B | 2.63B | 2.21B | 2.02B |
| Stockholders Equity | 15.38B | 16.11B | 16.15B | 15.01B | 13.42B | 13.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 771.97M | 2.37B | 538.34M | 1.64B | 2.82B |
| Operating Cash Flow | 0.00 | 878.18M | 2.53B | 589.82M | 1.74B | 2.92B |
| Investing Cash Flow | 0.00 | -9.82M | 1.41B | -63.30M | -47.03M | -104.33M |
| Financing Cash Flow | 0.00 | -852.92M | -158.29M | -166.47M | -271.31M | -84.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥39.40B | 5.65 | ― | 2.40% | 13.49% | 9.05% | |
73 Outperform | ¥66.18B | 23.18 | ― | 2.73% | 6.41% | 16.71% | |
66 Neutral | ¥176.54B | 8.81 | 13.53% | 1.34% | 0.48% | -1.86% | |
66 Neutral | ¥87.14B | 12.03 | ― | 1.99% | 3.71% | -3.32% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥22.90B | 3.36 | ― | 3.42% | -21.21% | -55.72% | |
54 Neutral | ¥2.78B | -1.57 | ― | 4.68% | 3.64% | 37.31% |